Effectiveness and Safety of Dabigatran, Rivaroxaban, and Apixaban Versus Warfarin in Nonvalvular Atrial Fibrillation

BACKGROUND: The introduction of non–vitamin K antagonist oral anticoagulants has been a major advance for stroke prevention in atrial fibrillation; however, outcomes achieved in clinical trials may not translate to routine practice. We aimed to evaluate the effectiveness and safety of dabigatran, ri...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Am Heart Assoc
Main Authors: Yao, Xiaoxi, Abraham, Neena S., Sangaralingham, Lindsey R., Bellolio, M. Fernanda, McBane, Robert D., Shah, Nilay D., Noseworthy, Peter A.
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2016
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4937291/
https://ncbi.nlm.nih.gov/pubmed/27412905
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/JAHA.116.003725
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados